Video

Studying glaucoma epidemiology at the center of the Earth

Author(s):

David Hutton,Alex Delaney-Gesing
Conferences|GLAUCOMA 360

Donald L. Budenz, MD, MPH, shares the key takeaways from his Shaffer-Hetherington-Hoskins Lecture, focusing on glaucoma epidemiology, presented during the 2021 Glaucoma 360's 25th Annual Glaucoma Symposium CME.

See more Glaucoma 360 coverage here

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
Related Content
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
Published: December 19th 2024 | Updated: December 19th 2024

Study validates long-term efficacy of MicroPulse TLT for glaucoma management

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
December 11th 2024

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024

Study highlights current and potential roles of AI in glaucoma diagnosis

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
December 6th 2024

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

© 2024 MJH Life Sciences

All rights reserved.